m6A-centered Crosstalk Information
Mechanism of Crosstalk between m6A Modification and Epigenetic Regulation
| Crosstalk ID |
M6ACROT00023
|
[1] | |||
: modification sites
Direct
Enhancement
m6A modification
Circ_FAM20B
Circ_FAM20B
YTHDF2
: m6A sites
|
|||||
| m6A Modification: | |||||
|---|---|---|---|---|---|
| m6A Regulator | YTH domain-containing family protein 2 (YTHDF2) | READER | |||
| m6A Target | Circ_FAM20B | ||||
| Epigenetic Regulation that have Cross-talk with This m6A Modification: | |||||
| Epigenetic Regulation Type | RNA modification (RNAMod) >> N1-methyladenosine (m1A) | ||||
| Epigenetic Regulator | tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6 (TRMT6) | WRITER | View Details | ||
| Regulated Target | Circ_FAM20B | View Details | |||
| Crosstalk Relationship | m1A → m6A | Enhancement | |||
| Crosstalk Mechanism | RNA modification directly impacts m6A modification through recruiting m6A regulator and targeting the shared RNA | ||||
| Crosstalk Summary | A subset of endogenous RNAs (cMATR3; Circ_FAM20B and cSLC45A4) that harbor m6A and associate with YTHDF2 in an HRSP12-dependent manner is also subjected to m1A-facilitated rapid degradation. The m1A modification is mediated by the TRMT6/TRMT61A complex. | ||||
| Pathway Response | RNA degradation | hsa03018 | |||
| Cell Process | mRNA decay | ||||
In-vitro Model |
HeLa | Endocervical adenocarcinoma | Homo sapiens | CVCL_0030 | |
: modification sites
: m6A sites